RedHill Biopharma Ltd.

NasdaqCM:RDHL Stock Report

Market Cap: US$8.8m

RedHill Biopharma Management

Management criteria checks 4/4

RedHill Biopharma's CEO is Dror Ben-Asher, appointed in Aug 2009, has a tenure of 15.33 years. total yearly compensation is $594.61K, comprised of 79.6% salary and 20.4% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth $2.70K. The average tenure of the management team and the board of directors is 5 years and 13.6 years respectively.

Key information

Dror Ben-Asher

Chief executive officer

US$594.6k

Total compensation

CEO salary percentage79.6%
CEO tenure15.3yrs
CEO ownership0.03%
Management average tenure5yrs
Board average tenure13.6yrs

Recent management updates

This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate

Sep 10
This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate

Recent updates

This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate

Sep 10
This Is Why RedHill Biopharma Ltd.'s (NASDAQ:RDHL) CEO Compensation Looks Appropriate

RedHill Biopharma Ltd. (NASDAQ:RDHL) Might Not Be As Mispriced As It Looks

Jul 28
RedHill Biopharma Ltd. (NASDAQ:RDHL) Might Not Be As Mispriced As It Looks

One RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Has Been Cutting Their Forecasts

Nov 24
One RedHill Biopharma Ltd. (NASDAQ:RDHL) Analyst Has Been Cutting Their Forecasts

RedHill Biopharma receives Nasdaq notification regarding minimum bid price deficiency

Oct 18

RedHill wins EU’s orphan drug status to RHB-204 for rare lung disease

Aug 17

RedHill: Given Up For Dead

Apr 30

RedHill Biopharma: Looking At An Unexciting Dead-End

Dec 30

CEO Compensation Analysis

How has Dror Ben-Asher's remuneration changed compared to RedHill Biopharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$30m

Mar 31 2024n/an/a

-US$28m

Dec 31 2023US$595kUS$473k

US$24m

Sep 30 2023n/an/a

US$34m

Jun 30 2023n/an/a

US$12m

Mar 31 2023n/an/a

-US$900k

Dec 31 2022US$865kUS$601k

-US$72m

Sep 30 2022n/an/a

-US$92m

Jun 30 2022n/an/a

-US$78m

Mar 31 2022n/an/a

-US$95m

Dec 31 2021US$1mUS$717k

-US$98m

Sep 30 2021n/an/a

-US$98m

Jun 30 2021n/an/a

-US$95m

Mar 31 2021n/an/a

-US$82m

Dec 31 2020US$817kUS$445k

-US$76m

Sep 30 2020n/an/a

-US$64m

Jun 30 2020n/an/a

-US$55m

Mar 31 2020n/an/a

-US$50m

Dec 31 2019US$708kUS$355k

-US$42m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$39m

Mar 31 2019n/an/a

-US$39m

Dec 31 2018US$576kUS$352k

-US$39m

Sep 30 2018n/an/a

-US$42m

Jun 30 2018n/an/a

-US$47m

Mar 31 2018n/an/a

-US$47m

Dec 31 2017US$634kUS$336k

-US$46m

Compensation vs Market: Dror's total compensation ($USD594.61K) is about average for companies of similar size in the US market ($USD646.54K).

Compensation vs Earnings: Dror's compensation has been consistent with company performance over the past year.

CEO

Dror Ben-Asher (58 yo)

15.3yrs

Tenure

US$594,612

Compensation

Mr. Dror Ben-Asher Co-Founded at RedHill Biopharma Ltd. and has been its Chief Executive Officer since August 3, 2009. Mr. Ben-Asher serves as an Associate of Mercator Group, LLC.He has been affiliated wi...

Leadership Team

NamePositionTenureCompensationOwnership
Dror Ben-Asher
Co-Founder15.3yrsUS$594.61k0.031%
$ 2.7k
Razi Ingber
Chief Financial Officer1.6yrsUS$354.22k0.013%
$ 1.2k
Gilead Raday
Chief Operating Officer8.7yrsUS$379.96k0.019%
$ 1.7k
Adi Frish
Chief Corporate & Business Development Officer4.2yrsUS$353.70k0.021%
$ 1.8k
Rick Scruggs
Chief Commercial Officer5.8yrsUS$469.80k0.0089%
$ 787.5
Alexandra Okmian
Senior Business Development & Investor Relations Manager5yrsno datano data
Reza Fathi
Senior Vice President of Research & Development1.4yrsUS$419.98k0.014%
$ 1.2k
Guy Goldberg
Chief Business Officer12.4yrsUS$504.63k0.013%
$ 1.1k
Patricia Anderson
Senior Vice President of Regulatory Affairs1.4yrsno datano data

5.0yrs

Average Tenure

54yo

Average Age

Experienced Management: RDHL's management team is seasoned and experienced (5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dror Ben-Asher
Co-Founder15.3yrsUS$594.61k0.031%
$ 2.7k
Rick Scruggs
Chief Commercial Officer8.9yrsUS$469.80k0.0089%
$ 787.5
Ofer Tsimchi
Independent Director13.6yrsno data0.0012%
$ 103.5
Werner Tschollar
Member of Advisory Boardno datano datano data
Ira Kalfus
Member of Advisory Board5.9yrsno datano data
Thomas Borody
Member of Advisory Boardno datano datano data
Shmuel Cabilly
Independent Director5.3yrsno data0.041%
$ 3.6k
Yechezkel Barenholz
Member of Advisory Boardno datano datano data
Ran Oren
Member of Advisory Boardno datano datano data
Eric Swenden
Independent Director14.6yrsno data0.0095%
$ 843.3
Kenneth Reed
Independent Director15yrsno data0.061%
$ 5.4k
Jerry Rosenblatt
Member of Advisory Boardno datano datano data

13.6yrs

Average Tenure

65yo

Average Age

Experienced Board: RDHL's board of directors are seasoned and experienced ( 13.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 07:26
End of Day Share Price 2024/12/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RedHill Biopharma Ltd. is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
null nullBTIG
Brandon FolkesCantor Fitzgerald & Co.